Mitsubishi UFJ Asset Management Co. Ltd. Increases Holdings in Axon Enterprise, Inc $AXON

Mitsubishi UFJ Asset Management Co. Ltd. grew its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 8.2% during the third quarter, according to the company in its most recent filing with the SEC. The fund owned 157,529 shares of the biotechnology company’s stock after acquiring an additional 11,902 shares during the quarter. Mitsubishi UFJ Asset Management Co. Ltd. owned about 0.20% of Axon Enterprise worth $113,049,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also made changes to their positions in the business. Westside Investment Management Inc. boosted its holdings in Axon Enterprise by 4.8% in the second quarter. Westside Investment Management Inc. now owns 283 shares of the biotechnology company’s stock valued at $225,000 after purchasing an additional 13 shares in the last quarter. Newbridge Financial Services Group Inc. lifted its position in shares of Axon Enterprise by 2.8% during the 2nd quarter. Newbridge Financial Services Group Inc. now owns 508 shares of the biotechnology company’s stock worth $421,000 after buying an additional 14 shares during the last quarter. Vicus Capital boosted its holdings in shares of Axon Enterprise by 3.7% in the 3rd quarter. Vicus Capital now owns 396 shares of the biotechnology company’s stock valued at $284,000 after buying an additional 14 shares in the last quarter. Evergreen Capital Management LLC grew its position in shares of Axon Enterprise by 3.8% in the 2nd quarter. Evergreen Capital Management LLC now owns 413 shares of the biotechnology company’s stock valued at $342,000 after buying an additional 15 shares during the last quarter. Finally, STF Management LP raised its stake in Axon Enterprise by 1.4% during the 2nd quarter. STF Management LP now owns 1,164 shares of the biotechnology company’s stock worth $964,000 after acquiring an additional 16 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $550.19 on Friday. The stock’s 50-day moving average price is $538.95 and its 200 day moving average price is $627.46. The company has a quick ratio of 2.89, a current ratio of 2.53 and a debt-to-equity ratio of 0.53. The stock has a market capitalization of $43.42 billion, a PE ratio of 361.97, a price-to-earnings-growth ratio of 15.67 and a beta of 1.48. Axon Enterprise, Inc has a 52-week low of $396.41 and a 52-week high of $885.91.

Axon Enterprise (NASDAQ:AXON) last announced its earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, beating the consensus estimate of $1.60 by $0.55. The company had revenue of $796.72 million for the quarter, compared to the consensus estimate of $755.29 million. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The company’s revenue was up 38.5% on a year-over-year basis. During the same period last year, the business posted $2.08 EPS. As a group, equities research analysts forecast that Axon Enterprise, Inc will post 5.8 EPS for the current year.

Axon Enterprise News Summary

Here are the key news stories impacting Axon Enterprise this week:

• Positive Sentiment: Q4 results materially beat expectations — revenue +39% to ~$796.7M and non‑GAAP EPS $2.15 vs. consensus — and management reiterated aggressive growth targets and large contracted bookings, which drove investor optimism. Axon’s Q4 Earnings Top Estimates
• Positive Sentiment: Company highlighted AI adoption across its device + software platform (body cams, TASER 10, evidence management) and reported strong net revenue retention and bookings/backlog growth — messaging that the hardware‑to‑software flywheel reduces AI disruption risk and supports revenue expansion. Taser Maker Axon Says Its Business Is Being ‘Supercharged by AI.’
• Positive Sentiment: Market reaction: multiple outlets and analysts upgraded tone or reiterated buy cases based on the beat and 2026+ targets, lifting momentum after a prior steep selloff tied to SaaS/AI fears. Taser-maker Axon pops 18% as AI boosts demand
• Neutral Sentiment: Analyst price‑target revisions are mixed: several firms trimmed targets post‑report (Barclays, Morgan Stanley, Piper Sandler) but many maintain overweight/buy views — the market is re‑pricing near‑term risk while keeping upside scenarios. These Analysts Cut Their Forecasts On Axon
• Neutral Sentiment: Short-interest data in the feed appears anomalous (reporting 0 shares / NaN changes) and shows no meaningful days‑to‑cover signal — treat that data as unreliable for trading decisions today.
• Negative Sentiment: An insider transaction: CEO Patrick W. Smith sold 10,000 shares at ~$500.24 (filed with the SEC). The sale is small relative to total holdings but may be viewed negatively by some traders. SEC Form 4
• Negative Sentiment: Profitability caveat: several pieces note that while top‑line growth is accelerating, margins/profitability have not fully caught up — a risk if investors rotate to profitability metrics. Axon Stock Is On Fire, But Here’s the Bad News

Analyst Ratings Changes

A number of equities research analysts recently weighed in on the stock. TD Cowen reissued a “buy” rating on shares of Axon Enterprise in a research report on Wednesday, November 5th. Royal Bank Of Canada cut their target price on Axon Enterprise from $860.00 to $735.00 and set an “outperform” rating on the stock in a research report on Wednesday. Craig Hallum reissued a “buy” rating and issued a $820.00 target price on shares of Axon Enterprise in a research report on Wednesday. Morgan Stanley dropped their price target on Axon Enterprise from $713.00 to $675.00 and set an “overweight” rating on the stock in a research note on Wednesday. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a research note on Monday, December 29th. Sixteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Axon Enterprise has an average rating of “Moderate Buy” and a consensus price target of $762.93.

Insider Buying and Selling

In other news, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction dated Monday, December 8th. The shares were sold at an average price of $551.92, for a total transaction of $5,519,200.00. Following the transaction, the chief executive officer directly owned 3,110,997 shares in the company, valued at $1,717,021,464.24. The trade was a 0.32% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Jeffrey C. Kunins sold 1,797 shares of the stock in a transaction dated Tuesday, December 2nd. The stock was sold at an average price of $539.23, for a total transaction of $968,996.31. Following the transaction, the insider directly owned 83,485 shares of the company’s stock, valued at $45,017,616.55. This represents a 2.11% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 58,040 shares of company stock worth $32,251,738 in the last ninety days. Insiders own 4.40% of the company’s stock.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.